Business Insider

Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination | Markets Insider

The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders is an expected $1.2 billion. Tevogen Bio is an advanced-stage specialty ...
Fox 5 San Diego

Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio

New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced ...
WDTN

Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc

New York, NY, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST) (“Semper Paratus”), a publicly traded special purpose acquisition company, today announced the ...
Seeking Alpha

Tevogen to go public via merger with SPAC Semper Paratus

Immunotherapy developer Tevogen (TVGN) plans to go public through a merger with SPAC Semper Paratus Acquisition Corp. (NASDAQ:LGST), with the deal estimating the enterprise value of the combined ...